RxNorm 2105653 NDC Crossover
VITRAKVI 20 MG in 1 mL Oral Solution
Related NDC Codes to RxNorm Concept 2105653
The following NDC codes crossover to the RxNorm Concept 2105653. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Status | |
---|---|---|---|---|---|---|---|
50419-390 | Vitrakvi | Larotrectinib | Capsule | Oral | Bayer Healthcare Pharmaceuticals Inc. | ACTIVE | |
50419-391 | Vitrakvi | Larotrectinib | Capsule | Oral | Bayer Healthcare Pharmaceuticals Inc. | ACTIVE | |
50419-392 | Vitrakvi | Larotrectinib | Solution, Concentrate | Oropharyngeal | Bayer Healthcare Pharmaceuticals Inc. | ACTIVE | |
50419-393 | Vitrakvi | Larotrectinib | Solution, Concentrate | Oropharyngeal | Bayer Healthcare Pharmaceuticals Inc. | ACTIVE | |
71777-390 | Vitrakvi | Larotrectinib | Capsule | Oral | Loxo Oncology, Inc. | ACTIVE | |
71777-391 | Vitrakvi | Larotrectinib | Capsule | Oral | Loxo Oncology, Inc. | ACTIVE | |
71777-392 | Vitrakvi | Larotrectinib | Solution | Oral | Loxo Oncology, Inc. | ACTIVE |